Description

Flixotid Evochaler (Fluticasone Propionate) Aerosolum 50 mcg. 120 doses

Ingredients

Active ingredient: Fluticasone propionate
Other ingredients: lactose monohydrate, magnesium stearate, and hydrofluoroalkane (HFA 134a)

Dosage

Recommended dosage: 1-2 inhalations twice daily. Consult a healthcare professional for personalized dosing instructions.

Indications

Indicated for: Maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older.

Contraindications

Do not use: In the primary treatment of status asthmaticus or acute episodes of asthma requiring intensive measures.

Directions

Shake well before each use. Inhale the prescribed dose by mouth as directed by your healthcare provider. Rinse your mouth with water after each use.

Scientific Evidence

Fluticasone propionate has been extensively studied for its efficacy in managing asthma symptoms. Research published in the Journal of Allergy and Clinical Immunology has shown that fluticasone propionate inhalers significantly improve lung function and reduce asthma exacerbations compared to placebo.

Additional Information

It is important to use Flixotid Evochaler regularly to receive the maximum benefit. Keep track of the number of doses used and discard the inhaler after the labeled number of doses has been used. Store at room temperature away from moisture and heat.

Pharmacological Effects: Fluticasone propionate, a synthetic corticosteroid, exerts its anti-inflammatory action by inhibiting multiple cell types and mediators involved in the asthmatic response. It reduces airway hyperresponsiveness and inflammation, leading to improved asthma control.

Clinical Trials: Clinical trials have demonstrated the superior efficacy of fluticasone propionate in reducing asthma symptoms and improving lung function compared to other corticosteroids. A study published in Respiratory Medicine showed that patients using fluticasone propionate had a significant decrease in asthma exacerbations and hospitalizations.